Navigation Links
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
Date:2/13/2008

lucosidase alfa),

which has been constrained by limited product supply, as the FDA has

yet to approve the larger scale manufacturing process for this product.

This supply constraint will have an estimated impact of $0.03 per

diluted share during the first quarter.

Product Sales

-- Sales of Myozyme are expected to increase to $320-$330 million this

year, compared with $201 million last year. The launch of this product

has been the most rapid for any of Genzyme's lysosomal storage disorder

treatments. In December, Genzyme announced that its post-marketing

Late-Onset Treatment Study of Myozyme met its co-primary endpoints,

confirming the benefit of the product for patients across the spectrum

of Pompe disease. The company has begun submitting the results of this

study for presentation at medical meetings and will pursue the

inclusion of the trial results in the product's labeling.

-- Sales of Fabrazyme(R) (agalsidase beta) are expected to reach $495-$505

million this year, compared with $424 million in 2007. The European

Commission has granted full marketing authorization for Fabrazyme,

making the product the only Fabry disease treatment to earn this

designation in Europe.

-- Sales of Cerezyme(R) (imiglucerase for injection) are expected to reach

$1.22-$1.24 billion this year, compared with $1.13 billion in 2007.

-- Sales of sevelamer therapies Renagel(R) (sevelamer hydrochloride) and

Renvela(R) (sevelamer carbonate) are expected to rise to $690-$700

million this year, compared with $603 million in 2007. Renvela was

approved by the FDA in October for the treatment of hemodialysis

patients, and Genzyme plans to launch the product on March 1. Genzyme

is currently engaged in active discussions with the FDA to expand the

product'
'/>"/>

SOURCE Genzyme Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. Genzyme Receives FDA Response Letter on Synvisc-One(TM)
2. Bioenvision Shareholders Approve Acquisition by Genzyme Corporation
3. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
4. Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS
5. Delaware Court Approves Bioenvision, Genzyme Joint Petition
6. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
7. Liquent Insight Publisher 3.6 Delivers Advanced Submission Capabilities
8. March of Dimes Delivers a New Look
9. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
10. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study
11. Gleevec, the targeted cancer pill, delivers more good news to patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... and distribution of a wide variety of nutritional and wellness products, announced the ... therapist that specializes in massage therapy, active isolated stretching and the prevention and ...
(Date:7/31/2015)... ... 31, 2015 , ... Intellitec Solutions announced today they have ... Dynamics GP for a senior living facility in Maine. Having achieved recognition as ... in 16 states. This further expansion was again a factor of the firm’s ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and the growing number of individuals who remain undiagnosed, treatment options for patients ... shy away from traditional CPAP therapy due to its overall lack of comfort ...
(Date:7/30/2015)... , ... July 31, 2015 , ... ... Errors By 50% or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, ... a 15 year veteran of helping drug, biologic and device firms reduce manufacturing ...
(Date:7/30/2015)... , ... July 31, 2015 , ... Committed to helping ... action by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” ... our young people stay on track. Providing the support they need to think more ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3
... Reinberg HealthDay Reporter , SUNDAY, Oct. 3 (HealthDay ... are poor or black fare worse than others if they ... financial and racial factors that impact diagnosis, treatment and survival, ... the American Association for Cancer Research in Miami. Lack ...
... October 2010 Elsevier, a world-leading publisher of scientific, technical ... the launch of a new journal, Developmental Cognitive Neuroscience ... will be available at the Society for Neuroscience 40th Annual ... ,It is with a sense of excitement that we ...
... detect small signs of increased tremor and impaired motor ... follow up the treatment of neurological disorders, reveals a ... aim was to investigate whether quantitative measurement methods, in ... detect small changes in tremor or other motor,functions resulting ...
... FRANCISCO O. Marion Burton, MD, FAAP, will serve ... Pediatrics (AAP) beginning Monday, Oct. 4, at the AAP ... in San Francisco. The AAP is the nation,s largest ... pediatricians, pediatric medical subspecialists and pediatric surgical specialists. ...
... Researchers at Queen,s University Belfast have completed one of the ... drug was outlawed earlier this year. They found that the ... the substance. Interviews with 23 mephedrone users were ... the legislation that made the drug illegal in the UK. ...
... Oregon Health &Science University may have uncovered a new ... mother to newborn child. The research, which was led ... will be published in the October 3rd online edition ... "Mother-to-infant transmission of HIV is a tremendous worldwide problem, ...
Cached Medicine News:Health News:Insurance, Race and Poverty Affect Cancer Care, Researchers Report 2Health News:Insurance, Race and Poverty Affect Cancer Care, Researchers Report 3Health News:Elsevier launches new journal: Developmental Cognitive Neuroscience 2Health News:Effective methods for detecting early signs of tremor 2Health News:O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president 2Health News:Study focuses on mephedrone use in Northern Ireland post-ban 2Health News:OHSU research reveals possible method for boosting the immune system to protect infants against HIV 2Health News:OHSU research reveals possible method for boosting the immune system to protect infants against HIV 3
(Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... 16 A new application developed by American ... pharmaceuticals has increased health plan staff productivity and the number ... diagnostic imaging benefit management and technology company with health plan ... of WellPoint, Inc. (NYSE: WLP ), adapted the ...
... , GREEN BAY, Wis., Dec. 16 ... Biotech for the use of super absorbency BCM-95® ... formulations. The exclusive distribution territory for these ... channel and professional channel, which includes allopathic doctors, ...
Cached Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3
...
... features an advanced design that accommodates both ... gives surgeons the flexibility to easily customize ... is built-in to every aspect of the ... Secure-Twist anti-migration system to the screw options ...
... is designed to meet the clinical challenges ... attached locking mechanism and the choice of ... variable angle screws for ease of implantation ... plate system allows the surgeon the versatility ...
... Revolutions start with small things. ... is one of the trailblazers of ... reflecting the,trend towards ever smaller access ... the operation site. ,The HiLAN XS ...
Medicine Products: